z-logo
open-access-imgOpen Access
Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model
Author(s) -
Ayse Nur HAZARYAVUZ,
Sila YILDIZ,
Rümeysa KELEŞ,
Muhammet Emin Çam,
Levent KABASAKAL
Publication year - 2022
Publication title -
journal of research in pharmacy
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2630-6344
DOI - 10.29228/jrp.128
Subject(s) - dapagliflozin , transporter , glucose transporter , medicine , pharmacology , endocrinology , chemistry , diabetes mellitus , type 2 diabetes , biochemistry , insulin , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom